| http://www.w3.org/ns/prov#value | - Patients with a chronic progressive MS course showed increasing HPA axis activity.12- 14 Another reason why the findings are inconsistent may be that the study population of Heesen et al28 received immunomodulatory and immunosuppressive agents such as interferons, glatiramer acetate, methotrexate, and mitoxantrone, whereas patients being treated with such medications were excluded from other studi
|
